Skip to main content
. Author manuscript; available in PMC: 2013 Apr 12.
Published in final edited form as: Clin Adv Hematol Oncol. 2013 Jan;11(1):14–23.

Figure 1.

Figure 1

Proportional prostate cancer clinical states model. The circles represent the proportional prevalence of each disease state. Adapted from the prostate cancer clinical states model43 and the prostate cancer clinical states prevalence model.44 mCRPC=metastatic castration-resistant prostate cancer; PSA=prostate-specific antigen.